Oncology remains the largest therapy area in the pharmaceutical industry, reflecting the scale and impact of cancer as a leading cause of death globally. Sustained market growth, accelerating innovation and rising complexity across cancer indications and therapeutic approaches are already reshaping oncology treatments and clinical practice.

This webinar will explore the evolving oncology landscape, including:

• Global oncology market dynamics, with insights into growth trends and variation across cancer indications
• A deep dive into haematological cancers, focusing on key areas of unmet need and breakthrough treatments, including CAR-T therapy
• How therapeutic innovation and diagnostics, such as circulating tumour DNA (ctDNA) testing, are reshaping precision oncology
• The evolving oncology launch environment to 2030, and what success will look like as competition continues to intensify

Join us to learn what these shifts mean for innovation, strategy and launch success.